In vivo bioluminescence imaging reveals copper deficiency in a murine model of nonalcoholic fatty liver disease

Marie Heffern, Hyo Min Park, Ho Yu Au-Yeung, Genevieve C. Van De Bittner, Cheri M. Ackerman, Andreas Stahl, Christopher J. Chang

Research output: Contribution to journalArticle

52 Citations (Scopus)

Abstract

Copper is a required metal nutrient for life, but global or local alterations in its homeostasis are linked to diseases spanning genetic and metabolic disorders to cancer and neurodegeneration. Technologies that enable longitudinal in vivo monitoring of dynamic copper pools can help meet the need to study the complex interplay between copper status, health, and disease in the same living organism over time. Here, we present the synthesis, characterization, and in vivo imaging applications of Copper-Caged Luciferin-1 (CCL-1), a bioluminescent reporter for tissue-specific copper visualization in living animals. CCL-1 uses a selective copper(I)-dependent oxidative cleavage reaction to release D-luciferin for subsequent bioluminescent reaction with firefly luciferase. The probe can detect physiological changes in labile Cu+ levels in live cells and mice under situations of copper deficiency or overload. Application of CCL-1 to mice with liver-specific luciferase expression in a diet-induced model of nonalcoholic fatty liver disease reveals onset of hepatic copper deficiency and altered expression levels of central copper trafficking proteins that accompany symptoms of glucose intolerance and weight gain. The data connect copper dysregulation to metabolic liver disease and provide a starting point for expanding the toolbox of reactivity-based chemical reporters for cell- And tissue-specific in vivo imaging.

Original languageEnglish (US)
Pages (from-to)14219-14224
Number of pages6
JournalProceedings of the National Academy of Sciences of the United States of America
Volume113
Issue number50
DOIs
StatePublished - Dec 13 2016
Externally publishedYes

Fingerprint

Copper
Metabolic Diseases
Non-alcoholic Fatty Liver Disease
Firefly Luciferases
Inborn Genetic Diseases
Glucose Intolerance
Liver
Protein Transport
Luciferases
Health Status
Weight Gain
Liver Diseases
Homeostasis
Metals
Diet
Technology
Food

Keywords

  • Copper
  • Luciferin
  • Metabolic liver disease
  • Metal homeostasis
  • Molecular imaging

ASJC Scopus subject areas

  • General

Cite this

In vivo bioluminescence imaging reveals copper deficiency in a murine model of nonalcoholic fatty liver disease. / Heffern, Marie; Park, Hyo Min; Au-Yeung, Ho Yu; Van De Bittner, Genevieve C.; Ackerman, Cheri M.; Stahl, Andreas; Chang, Christopher J.

In: Proceedings of the National Academy of Sciences of the United States of America, Vol. 113, No. 50, 13.12.2016, p. 14219-14224.

Research output: Contribution to journalArticle

Heffern, Marie ; Park, Hyo Min ; Au-Yeung, Ho Yu ; Van De Bittner, Genevieve C. ; Ackerman, Cheri M. ; Stahl, Andreas ; Chang, Christopher J. / In vivo bioluminescence imaging reveals copper deficiency in a murine model of nonalcoholic fatty liver disease. In: Proceedings of the National Academy of Sciences of the United States of America. 2016 ; Vol. 113, No. 50. pp. 14219-14224.
@article{c8bfda3cc961468aa9952d7720096215,
title = "In vivo bioluminescence imaging reveals copper deficiency in a murine model of nonalcoholic fatty liver disease",
abstract = "Copper is a required metal nutrient for life, but global or local alterations in its homeostasis are linked to diseases spanning genetic and metabolic disorders to cancer and neurodegeneration. Technologies that enable longitudinal in vivo monitoring of dynamic copper pools can help meet the need to study the complex interplay between copper status, health, and disease in the same living organism over time. Here, we present the synthesis, characterization, and in vivo imaging applications of Copper-Caged Luciferin-1 (CCL-1), a bioluminescent reporter for tissue-specific copper visualization in living animals. CCL-1 uses a selective copper(I)-dependent oxidative cleavage reaction to release D-luciferin for subsequent bioluminescent reaction with firefly luciferase. The probe can detect physiological changes in labile Cu+ levels in live cells and mice under situations of copper deficiency or overload. Application of CCL-1 to mice with liver-specific luciferase expression in a diet-induced model of nonalcoholic fatty liver disease reveals onset of hepatic copper deficiency and altered expression levels of central copper trafficking proteins that accompany symptoms of glucose intolerance and weight gain. The data connect copper dysregulation to metabolic liver disease and provide a starting point for expanding the toolbox of reactivity-based chemical reporters for cell- And tissue-specific in vivo imaging.",
keywords = "Copper, Luciferin, Metabolic liver disease, Metal homeostasis, Molecular imaging",
author = "Marie Heffern and Park, {Hyo Min} and Au-Yeung, {Ho Yu} and {Van De Bittner}, {Genevieve C.} and Ackerman, {Cheri M.} and Andreas Stahl and Chang, {Christopher J.}",
year = "2016",
month = "12",
day = "13",
doi = "10.1073/pnas.1613628113",
language = "English (US)",
volume = "113",
pages = "14219--14224",
journal = "Proceedings of the National Academy of Sciences of the United States of America",
issn = "0027-8424",
number = "50",

}

TY - JOUR

T1 - In vivo bioluminescence imaging reveals copper deficiency in a murine model of nonalcoholic fatty liver disease

AU - Heffern, Marie

AU - Park, Hyo Min

AU - Au-Yeung, Ho Yu

AU - Van De Bittner, Genevieve C.

AU - Ackerman, Cheri M.

AU - Stahl, Andreas

AU - Chang, Christopher J.

PY - 2016/12/13

Y1 - 2016/12/13

N2 - Copper is a required metal nutrient for life, but global or local alterations in its homeostasis are linked to diseases spanning genetic and metabolic disorders to cancer and neurodegeneration. Technologies that enable longitudinal in vivo monitoring of dynamic copper pools can help meet the need to study the complex interplay between copper status, health, and disease in the same living organism over time. Here, we present the synthesis, characterization, and in vivo imaging applications of Copper-Caged Luciferin-1 (CCL-1), a bioluminescent reporter for tissue-specific copper visualization in living animals. CCL-1 uses a selective copper(I)-dependent oxidative cleavage reaction to release D-luciferin for subsequent bioluminescent reaction with firefly luciferase. The probe can detect physiological changes in labile Cu+ levels in live cells and mice under situations of copper deficiency or overload. Application of CCL-1 to mice with liver-specific luciferase expression in a diet-induced model of nonalcoholic fatty liver disease reveals onset of hepatic copper deficiency and altered expression levels of central copper trafficking proteins that accompany symptoms of glucose intolerance and weight gain. The data connect copper dysregulation to metabolic liver disease and provide a starting point for expanding the toolbox of reactivity-based chemical reporters for cell- And tissue-specific in vivo imaging.

AB - Copper is a required metal nutrient for life, but global or local alterations in its homeostasis are linked to diseases spanning genetic and metabolic disorders to cancer and neurodegeneration. Technologies that enable longitudinal in vivo monitoring of dynamic copper pools can help meet the need to study the complex interplay between copper status, health, and disease in the same living organism over time. Here, we present the synthesis, characterization, and in vivo imaging applications of Copper-Caged Luciferin-1 (CCL-1), a bioluminescent reporter for tissue-specific copper visualization in living animals. CCL-1 uses a selective copper(I)-dependent oxidative cleavage reaction to release D-luciferin for subsequent bioluminescent reaction with firefly luciferase. The probe can detect physiological changes in labile Cu+ levels in live cells and mice under situations of copper deficiency or overload. Application of CCL-1 to mice with liver-specific luciferase expression in a diet-induced model of nonalcoholic fatty liver disease reveals onset of hepatic copper deficiency and altered expression levels of central copper trafficking proteins that accompany symptoms of glucose intolerance and weight gain. The data connect copper dysregulation to metabolic liver disease and provide a starting point for expanding the toolbox of reactivity-based chemical reporters for cell- And tissue-specific in vivo imaging.

KW - Copper

KW - Luciferin

KW - Metabolic liver disease

KW - Metal homeostasis

KW - Molecular imaging

UR - http://www.scopus.com/inward/record.url?scp=85005949394&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85005949394&partnerID=8YFLogxK

U2 - 10.1073/pnas.1613628113

DO - 10.1073/pnas.1613628113

M3 - Article

C2 - 27911810

AN - SCOPUS:85005949394

VL - 113

SP - 14219

EP - 14224

JO - Proceedings of the National Academy of Sciences of the United States of America

JF - Proceedings of the National Academy of Sciences of the United States of America

SN - 0027-8424

IS - 50

ER -